[250 Pages Report] The global ultrasound-guided breast biopsy market is expected to reach US$ 1,090 Mn in 2032, exhibiting a CAGR of 8% during the forecast period. Ultrasound-guided biopsy market is currently valued at US$ 720 Mn in 2022. Rising incidence of breast cancer cases and increasing awareness about early diagnosis of breast cancer will push sales in the market over the forecast period.
| Report Attribute | Details |
|---|---|
| Ultrasound-Guided Breast Biopsy Market Size (2022) | US$ 720 million |
| Ultrasound-Guided Breast Biopsy Market Size (2032) | US$ 1,090 million |
| Ultrasound-Guided Breast Biopsy Market Projected Growth Rate (2022-2032) | 8% CAGR |
According to a 2021 report by WHO, there were 2.3 million women diagnosed with breast cancer and 685,000 deaths, globally, in the year 2020. In 2020, 7.8 million women were living with breast cancer, making it world’s most prevalent cancer.
Breast cancer forms either with the breast tissue which is made up of glands for milk production known as lobules or begins in the ducts. These abnormalities or lumps in the breasts are generally detected with mammography, physical examinations, or other imaging techniques such as ultrasound-guided breast biopsy.
In an ultrasound-guided breast biopsy, radiologists use ultrasound imaging as a guide to inspect the site of the abnormal cell growth. A breast biopsy with the aid of ultrasound is mostly performed when an abnormality such as a distortion of the breast tissue or a suspicious mass of solid is felt around the breast.
High rate of mortality and increasing incidence of breast cancer will underpin the adoption of ultrasound-guided breast biopsy over the assessment period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Ultrasound-guided breast biopsy is comparatively less invasive than other surgical biopsies, it leaves little scarring and can be performed in a limited time frame. These factors, combined together, will increase the adoption rate of ultrasound-guided breast biopsy.
In addition to this, ultrasound-guided breast biopsy does not carry ionizing radiation and provides faster results. It is also less expensive and has shorter recovery period. On the back of these factors, demand in the market is projected to increase at a considerable pace over the forecast period.
Ultrasound-guided breast biopsy also has certain aspects that impede sales in the market. The ultrasound-guided breast biopsy is known to carry a risk of bleeding that forms hematoma because of which consumers might reject this method of biopsy. This in turn hampers the growth in the ultrasound-guided breast biopsy market.
Furthermore, other factors such as discomfort experienced by patients during biopsy and the cost of an ultrasound machine might also impede the growth in ultrasound-guided breast biopsy market over the forecast period.
Principal Consultant
The American Cancer Society’s estimates for the year 2022 states that there will be 287,850 new cases of breast cancer, with 43,250 deaths. This rising prevalence of breast cancer along with an increasingly alert population may increase the demand for ultrasound-guided breast biopsy in North America.
Thus, ultrasound-guided breast biopsy market in North America is expected to exhibit a significant growth rate for the forecast period. Advancing technologies, high investments in the healthcare sector, and increasing production of new and improved imaging technologies will augment sales in the ultrasound-guided breast biopsy market in North America.
Increasing awareness regarding early diagnosis and treatment of breast cancer among individuals across Asia Pacific is expected to create opportunities for growth in the market. Owing to rising amount of campaigns about breast cancer, majority of the population is aware about diagnosis and treatment methods for breast cancer. This is expected to boost the Asia Pacific ultrasound-guided breast biopsy market over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Leading players operating in the global ultrasound-guided breast biopsy market include Hologic, Inc., Medsurge Ind Private Limited among others.
Key companies in the market are engaged in developing their portfolio of breast biopsy products and accessories. The focus is also on contracts and partnerships to launch insight driven products, product commercialization and pipeline development in order to strengthen market position.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
North America is set to lead ultrasound-guided breast biopsy market growth over the forecast period.
Hologic Inc. and Medsurge Ind Private Limited are the two key players in the ultrasound-guided breast biopsy market.
The global ultrasound-guided breast biopsy market is estimated to reach US$ 720 Mn in 2022.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Investment Feasibility Matrix 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure, 2022-2032 5.3.1. Fine Needle Aspiration (FNA) 5.3.2. Core Needle (CN) 5.3.3. Vacuum-assisted Device (VAD) 5.3.4. Wire Localization 5.4. Y-o-Y Growth Trend Analysis By Procedure, 2017-2021 5.5. Absolute $ Opportunity Analysis By Procedure, 2022-2032 6. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Diagnostics Laboratories 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032 7. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Procedure 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Procedure 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Procedure 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Procedure 9.3.3. By End User 9.4. Key Takeaways 10. Europe Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. Italy 10.2.1.3. France 10.2.1.4. U.K. 10.2.1.5. Russia 10.2.1.6. BENELUX 10.2.1.7. Rest of Europe 10.2.2. By Procedure 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Procedure 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Rest of Asia Pacific 11.2.2. By Procedure 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Procedure 11.3.3. By End User 11.4. Key Takeaways 12. Middle East and Africa Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Turkey 12.2.1.4. Rest of Middle East and Africa 12.2.2. By Procedure 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Procedure 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Ultrasound-Guided Breast Biopsy Market Analysis 13.1. U.S. 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Procedure 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Procedure 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Procedure 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Procedure 13.4.2.2. By End User 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Procedure 13.5.2.2. By End User 13.6. Italy 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Procedure 13.6.2.2. By End User 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Procedure 13.7.2.2. By End User 13.8. U.K. 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Procedure 13.8.2.2. By End User 13.9. Russia 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Procedure 13.9.2.2. By End User 13.10. BENELUX 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Procedure 13.10.2.2. By End User 13.11. China 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Procedure 13.11.2.2. By End User 13.12. Japan 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Procedure 13.12.2.2. By End User 13.13. South Korea 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Procedure 13.13.2.2. By End User 13.14. GCC Countries 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Procedure 13.14.2.2. By End User 13.15. South Africa 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Procedure 13.15.2.2. By End User 13.16. Turkey 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Procedure 13.16.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Procedure 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Hologic 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. Medsurge 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Ethicon Endo Surgery 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Galini 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Leica Biosystems 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Becton and Dickinson Company 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Cook Medical Incorporated 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. Argon Medical Devices 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Recommendations
Explore Healthcare Insights
View Reports
Ultrasound-Guided Breast Biopsy Market
